Rago V

ORCID: 0000-0003-3971-7378 · 1 paper in corpus
2017
Oncotarget ·doi:10.18632/oncotarget.23314

We previously demonstrated that treatment of the H295R adrenocortical cancer cell line with the non-steroidal, high-affinity GPER (G protein-coupled estrogen receptor 1) agonist G-1 reduced tumor growth in vitro and in vivo through a GPER i…